Natixis Advisors LLC Sells 176,920 Shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC)

Key Points

• Natixis Advisors LLC significantly reduced its stake in Acadia Healthcare by 90.6%, selling 176,920 shares and retaining 18,371 shares worth approximately $557,000.
• Acadia Healthcare's stock has seen several analysts' ratings changes, with upgrades to "hold" and price target revisions ranging from $31.00 to $55.00.
• The company reported a 9.2% increase in revenue year-over-year, achieving $869.23 million, and beat the earnings per share consensus estimate of $0.71 by $0.12.

Natixis Advisors LLC decreased its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) by 90.6% in the first quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 18,371 shares of the company's stock after selling 176,920 shares during the period. Natixis Advisors LLC's holdings in Acadia Healthcare were worth $557,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. UMB Bank n.a. boosted its stake in shares of Acadia Healthcare by 149.5% in the 1st quarter. UMB Bank n.a. now owns 1,260 shares of the company's stock valued at $38,000 after purchasing an additional 755 shares in the last quarter. State of Wyoming purchased a new stake in shares of Acadia Healthcare in the 4th quarter valued at $56,000. Covestor Ltd boosted its stake in shares of Acadia Healthcare by 27.2% in the 4th quarter. Covestor Ltd now owns 1,450 shares of the company's stock valued at $58,000 after purchasing an additional 310 shares in the last quarter. Aquatic Capital Management LLC purchased a new stake in Acadia Healthcare during the 4th quarter valued at $97,000. Finally, Sterling Capital Management LLC boosted its position in Acadia Healthcare by 59.1% during the 4th quarter. Sterling Capital Management LLC now owns 5,456 shares of the company's stock valued at $216,000 after buying an additional 2,026 shares during the period.

Acadia Healthcare Trading Up 1.5%

Shares of NASDAQ:ACHC traded up $0.32 on Friday, hitting $20.98. The company had a trading volume of 2,135,757 shares, compared to its average volume of 2,429,440. The firm's 50-day simple moving average is $21.97 and its two-hundred day simple moving average is $26.94. Acadia Healthcare Company, Inc. has a 1 year low of $17.13 and a 1 year high of $82.40. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $1.94 billion, a price-to-earnings ratio of 13.89, a P/E/G ratio of 4.08 and a beta of 0.88.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $0.83 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.71 by $0.12. The company had revenue of $869.23 million during the quarter, compared to analyst estimates of $839.59 million. Acadia Healthcare had a net margin of 4.31% and a return on equity of 8.34%. Acadia Healthcare's quarterly revenue was up 9.2% compared to the same quarter last year. During the same period last year, the business earned $0.91 EPS. Equities analysts anticipate that Acadia Healthcare Company, Inc. will post 3.38 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several equities research analysts have weighed in on the stock. KeyCorp dropped their price target on shares of Acadia Healthcare from $65.00 to $55.00 and set an "overweight" rating for the company in a research report on Wednesday, May 14th. Mizuho dropped their price target on shares of Acadia Healthcare from $32.00 to $22.00 and set a "neutral" rating for the company in a research report on Wednesday. Cowen reissued a "buy" rating on shares of Acadia Healthcare in a research report on Thursday, August 7th. Stephens raised shares of Acadia Healthcare to a "hold" rating in a research report on Monday, June 2nd. Finally, Guggenheim dropped their price target on shares of Acadia Healthcare from $36.00 to $29.00 and set a "buy" rating for the company in a research report on Thursday, August 7th. Five investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $40.77.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.